Publication | Closed Access

Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysis

InflammationRheumatologyAnti-tnf TherapyImmunologyGastroenterologyChronic InflammationPathologyLow Muscle MassEarly Treatment FailureUlcerative ColitisMedicineRheumatoid Arthritis